Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
44.94
+0.20 (+0.45%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Bristol-Myers Squibb's Options Frenzy: What You Need to Know
March 04, 2024
Via
Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss
February 28, 2024
Eli Lilly's CEO, David Ricks, outlines plans to launch the obesity drug Tirzepatide in India next year, presenting opportunities amid competition from Novo Nordisk. Bristol Myers Squibb expands its R&D...
Via
Benzinga
3 Highly Rated Biotech Stocks to Buy for 300% Gains
February 26, 2024
Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings.
Via
InvestorPlace
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
February 22, 2024
Via
Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
February 21, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
February 09, 2024
Via
Benzinga
Bristol-Myers Squibb Options Trading: A Deep Dive into Market Sentiment
February 05, 2024
Via
Benzinga
Mental Health Mavericks: 3 Stocks Changing the Game
February 21, 2024
Except for the psychedelics movement, there seem to be very few mental health stocks to buy that are making money.
Via
InvestorPlace
The 3 Best Stocks Beginning Investors Can Buy: February 2024
February 21, 2024
Starting your investment journey? Navigate the market with confidence! Discover 3 stocks for beginning investors in this article.
Via
InvestorPlace
Got $5,000? These 3 Stocks Are Dirt Cheap Buys With Plenty of Upside
February 21, 2024
Shares of these companies are trading at sizable earnings discounts.
Via
The Motley Fool
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
February 20, 2024
Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of president. Tom Shuman, a CPG sales and marketing veteran, agreed to serve as...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 17, 2024
Patience will be rewarded with these stocks.
Via
The Motley Fool
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts.
Via
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
February 14, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
7 Dividend Stocks to Buy at a 52-Week Low
February 12, 2024
Each of these dividend stocks has been down sharply in the last 12 months but has fundamental reasons that support a turnaround.
Via
InvestorPlace
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
February 09, 2024
Via
Benzinga
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.
Via
InvestorPlace
How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
February 08, 2024
Cytokinetics is looking to take on Bristol Myers Squibb in treating a heart disease.
Via
Investor's Business Daily
3 Blue-Chip Stocks to Buy at a 52-Week Low in February
February 07, 2024
Higher-for-longer interest rates and undervalued metrics make it a good time to look for blue-chip stocks at a low price.
Via
InvestorPlace
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.
Via
Benzinga
Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
February 06, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Undervalued Gems: 7 Stocks Set for a Major Rebound
February 05, 2024
Each of these seven undervalued stocks has fallen by 25% or more from its 52-week high, but may have a path back to prior prices.
Via
InvestorPlace
3 Blue Chip Dividend Stocks To Play Defense
February 02, 2024
We will discuss 3 long-term blue chip stocks to play defense. They have raised their dividends each year for over ten years, have current yields above the S&P 500 Index average, and should continue to...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript
February 02, 2024
BMY earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review
February 02, 2024
The Dow led the major indexes higher. Big techs diverged on results.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
What's Going On With US Pharma Giant Bristol-Myers Squibb Stock Today?
February 02, 2024
Bristol Myers Squibb reports Q4 revenues of $11.48 billion, up 1% YoY. Eliquis and Opdivo sales drive growth, offsetting Revlimid decline.
Via
Benzinga
Bristol Myers Shares Rise On Fourth-Quarter Earnings Beat
February 02, 2024
Bristol Myers earnings came in above expectations, although Opdivo sales were slower than expected. BMY stock gained.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.